Nautilus Biotechnolgy, Inc. (NAUT)
NASDAQ·Healthcare·Biotechnology
$2.35
+5.61%
Mkt Cap $291.68M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$3.50
Range $3.50 – $3.50
Implied Upside
+48.9%
Consensus $3.50 vs current $2.35
NASDAQ·Healthcare·Biotechnology
$2.35
+5.61%
Mkt Cap $291.68M
No recent rating data.
Price Target (3 analysts)
$3.50
Range $3.50 – $3.50
+48.9%
Consensus $3.50 vs current $2.35